CRL Jul 2024 180.000 put
| Previous close | 1.9500 |
| Open | 1.9500 |
| Bid | 0.4000 |
| Ask | 2.7500 |
| Strike | 180.00 |
| Expiry date | 2024-07-19 |
| Day's range | 1.9500 - 1.9500 |
| Contract range | N/A |
| Volume | |
| Open interest | 13 |
Business WireCharles River Launches Viral Vector Tech Transfer Program to Safeguard Gene Therapy Development
WILMINGTON, Mass., May 30, 2024--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the introduction of its Modular and Fast Track viral vector technology (tech) transfer frameworks. Based on decades of viral vector contract development and manufacturing organization (CDMO) experience, the Company has designed a methodical program to drive successful, accelerated process transfer to its Maryland-based viral vector center of excellence (CoE) in as little as nine months.
ZacksReasons to Hold Charles River (CRL) in Your Portfolio Now
Investors remain optimistic about Charles River (CRL), owing to its acquisitions, thriving DSA segment and financial stability.
ZacksCharles River (CRL) Banks on RMS Growth Amid Competition
Charles River's (CRL) RMS arm sees lesser impact on demand than other life science sectors despite macroeconomic challenges in China.
